AU2002365256A8 - Gemcitabine in the treatment of smallpox - Google Patents

Gemcitabine in the treatment of smallpox

Info

Publication number
AU2002365256A8
AU2002365256A8 AU2002365256A AU2002365256A AU2002365256A8 AU 2002365256 A8 AU2002365256 A8 AU 2002365256A8 AU 2002365256 A AU2002365256 A AU 2002365256A AU 2002365256 A AU2002365256 A AU 2002365256A AU 2002365256 A8 AU2002365256 A8 AU 2002365256A8
Authority
AU
Australia
Prior art keywords
smallpox
gemcitabine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365256A
Other versions
AU2002365256A1 (en
Inventor
John Irvin Glass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002365256A8 publication Critical patent/AU2002365256A8/en
Publication of AU2002365256A1 publication Critical patent/AU2002365256A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002365256A 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox Abandoned AU2002365256A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35662301P 2001-10-25 2001-10-25
US60/356,623 2001-10-25
PCT/US2002/031570 WO2003059334A2 (en) 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox

Publications (2)

Publication Number Publication Date
AU2002365256A8 true AU2002365256A8 (en) 2003-07-30
AU2002365256A1 AU2002365256A1 (en) 2003-07-30

Family

ID=23402228

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365256A Abandoned AU2002365256A1 (en) 2001-10-25 2002-10-15 Gemcitabine in the treatment of smallpox

Country Status (2)

Country Link
AU (1) AU2002365256A1 (en)
WO (1) WO2003059334A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117982522A (en) * 2022-11-02 2024-05-07 河南真实生物科技有限公司 Pharmaceutical use of nucleoside compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895937A (en) * 1982-01-05 1990-01-23 The Research Foundation Of State University Of New York 5-ioso-2-pyrimidinone nucleoside
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs

Also Published As

Publication number Publication date
WO2003059334A2 (en) 2003-07-24
WO2003059334A3 (en) 2003-10-30
AU2002365256A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
EP1463438A4 (en) Endomural therapy
GB0112343D0 (en) Well treatment
GB0113751D0 (en) Surface treatment
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB0126879D0 (en) Combination therapy
GB0108671D0 (en) Skin treatment
GB0101933D0 (en) Therapy
GB0108485D0 (en) Combination therapy
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
GB0130763D0 (en) Treatment methods
AU2002365256A8 (en) Gemcitabine in the treatment of smallpox
GB0103031D0 (en) Novel treatment
HU0200253D0 (en) Combination therapy
AU147595S (en) Hand spa
GB0128122D0 (en) Therapeutic use
PL367941A1 (en) The treatment of lipodystrophy
GB0130694D0 (en) Treatment
GB0104031D0 (en) Antiviral treatment
GB0104030D0 (en) Antiviral treatment
GB0108564D0 (en) Skin treatment
GB0116837D0 (en) Treatment
GB0109519D0 (en) Nimico treatment
GB0122594D0 (en) Hair treatment composition
GB2367242B (en) Antiviral treatment
GB0117419D0 (en) Novel treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase